Pre-market hot trades in US stocks: FabricAI pre-market up 9.63%, Kopin's increased holdings and micro LED technology spark market enthusiasm

Pre-market Hot Trades in US Stocks FabricAI is up 9.63% in pre-market trading. Based on recent key news: On May 4, Kopin submitted a Form 3 beneficial ownership statement regarding Fabric.ai, disclosing that it holds 10% of the shares. This news indicates increased market confidence in Fabric.ai, driving the stock price up. Source: EDGAR On May 6, two major chip manufacturers in the industry signed a confidentiality agreement, showing increased interest in micro LED-based optical interconnect technology. This development indicates the market potential of the technology, which may drive up the stock prices of related companies. Source: Industry news No other significant news recently. The micro LED technology has great market potential and high industry attention. Top Gainers in Pre-market US Stocks Global Engine is up 90.22% in pre-market trading. No significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no_news Rackspace Tech is up 57.27% in pre-market trading. Based on recent news, On May 7, Rackspace Technology signed a memorandum of understanding with AMD to establish a new category of enterprise AI infrastructure. This collaboration enhances market confidence in the company's future growth, significantly driving up the stock price. On May 7, Rackspace Technology announced its Q1 2026 financial report, with revenue of $678 million, a 2% year-over-year increase. Net income was $8.3 million, reversing a previous net loss. This financial performance exceeded market expectations, further boosting the stock price. On May 7, Rackspace Technology reaffirmed its guidance for 2026 and announced collaborations with several strategic partners and a debt reduction plan. These measures are seen by the market as strong support for the company's future growth, driving up the stock price. Increased demand for enterprise AI infrastructure is pushing up the stock prices of related companies. Atara Biotherapeutics is up 57.09% in pre-market trading. Based on recent news, On May 7, Atara Biotherapeutics announced that the FDA agreed that its single-arm study could support future market applications for TAB-CEL. This news significantly boosts market confidence in the company's future development, driving the stock price up substantially. On May 6, Atara Biotherapeutics is set to announce its Q1 2026 financial report, with market expectations of revenue at $2.9 million and earnings per share at -$0.33. Investors are optimistic about the upcoming financial report, further driving up the stock price. On May 7, Atara Biotherapeutics had productive discussions with the FDA regarding the supplemental submission for the TAB-CEL biologics license application The company plans to provide further regulatory updates in the third quarter, a news that has boosted market confidence in the company's future prospects. The biopharmaceutical industry has performed strongly recently, with positive regulatory progress